232 related articles for article (PubMed ID: 29789935)
1. Potential use of stem cells as a therapy for cystinosis.
Rocca CJ; Cherqui S
Pediatr Nephrol; 2019 Jun; 34(6):965-973. PubMed ID: 29789935
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside.
Cherqui S
Cells; 2021 Nov; 10(12):. PubMed ID: 34943781
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model.
Goodman S; Khan M; Sharma J; Li Z; Cano J; Castellanos C; Estrada MV; Gertsman I; Cherqui S
Mol Genet Metab; 2021 Dec; 134(4):309-316. PubMed ID: 34823997
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis.
Harrison F; Yeagy BA; Rocca CJ; Kohn DB; Salomon DR; Cherqui S
Mol Ther; 2013 Feb; 21(2):433-44. PubMed ID: 23089735
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation.
Rocca CJ; Kreymerman A; Ur SN; Frizzi KE; Naphade S; Lau A; Tran T; Calcutt NA; Goldberg JL; Cherqui S
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7214-23. PubMed ID: 26540660
[TBL] [Abstract][Full Text] [Related]
6. Is genetic rescue of cystinosis an achievable treatment goal?
Cherqui S
Nephrol Dial Transplant; 2014 Mar; 29(3):522-8. PubMed ID: 23861466
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model.
Gaide Chevronnay HP; Janssens V; Van Der Smissen P; Rocca CJ; Liao XH; Refetoff S; Pierreux CE; Cherqui S; Courtoy PJ
Endocrinology; 2016 Apr; 157(4):1363-71. PubMed ID: 26812160
[TBL] [Abstract][Full Text] [Related]
8. The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.
Cherqui S; Courtoy PJ
Nat Rev Nephrol; 2017 Feb; 13(2):115-131. PubMed ID: 27990015
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis: First human report.
Elmonem MA; Veys K; Oliveira Arcolino F; Van Dyck M; Benedetti MC; Diomedi-Camassei F; De Hertogh G; van den Heuvel LP; Renard M; Levtchenko E
Am J Transplant; 2018 Nov; 18(11):2823-2828. PubMed ID: 30030899
[TBL] [Abstract][Full Text] [Related]
10. [Cystinosis: From the gene identification to the first gene therapy clinical trial].
Cherqui S
Med Sci (Paris); 2023 Mar; 39(3):253-261. PubMed ID: 36943122
[TBL] [Abstract][Full Text] [Related]
11. Brief reports: Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes.
Naphade S; Sharma J; Gaide Chevronnay HP; Shook MA; Yeagy BA; Rocca CJ; Ur SN; Lau AJ; Courtoy PJ; Cherqui S
Stem Cells; 2015 Jan; 33(1):301-9. PubMed ID: 25186209
[TBL] [Abstract][Full Text] [Related]
12. Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.
Andrzejewska Z; Nevo N; Thomas L; Chhuon C; Bailleux A; Chauvet V; Courtoy PJ; Chol M; Guerrera IC; Antignac C
J Am Soc Nephrol; 2016 Jun; 27(6):1678-88. PubMed ID: 26449607
[TBL] [Abstract][Full Text] [Related]
13. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
[TBL] [Abstract][Full Text] [Related]
14. Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis.
Napolitano G; Johnson JL; He J; Rocca CJ; Monfregola J; Pestonjamasp K; Cherqui S; Catz SD
EMBO Mol Med; 2015 Feb; 7(2):158-74. PubMed ID: 25586965
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation.
Syres K; Harrison F; Tadlock M; Jester JV; Simpson J; Roy S; Salomon DR; Cherqui S
Blood; 2009 Sep; 114(12):2542-52. PubMed ID: 19506297
[TBL] [Abstract][Full Text] [Related]
16. Cystinosis: the evolution of a treatable disease.
Nesterova G; Gahl WA
Pediatr Nephrol; 2013 Jan; 28(1):51-9. PubMed ID: 22903658
[TBL] [Abstract][Full Text] [Related]
17. Cystinosis: a review.
Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E
Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer may be preventive but not curative for a lysosomal transport disorder.
Hippert C; Dubois G; Morin C; Disson O; Ibanes S; Jacquet C; Schwendener R; Antignac C; Kremer EJ; Kalatzis V
Mol Ther; 2008 Aug; 16(8):1372-81. PubMed ID: 18578013
[TBL] [Abstract][Full Text] [Related]
19. Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells.
Rega LR; Polishchuk E; Montefusco S; Napolitano G; Tozzi G; Zhang J; Bellomo F; Taranta A; Pastore A; Polishchuk R; Piemonte F; Medina DL; Catz SD; Ballabio A; Emma F
Kidney Int; 2016 Apr; 89(4):862-73. PubMed ID: 26994576
[TBL] [Abstract][Full Text] [Related]
20. New aspects of the pathogenesis of cystinosis.
Kalatzis V; Antignac C
Pediatr Nephrol; 2003 Mar; 18(3):207-15. PubMed ID: 12644911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
